Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 randomized, double-blind, placebo-controlled multiple-dose trial of GS-9411 in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• GS-9411

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis, Mucociliary Clearance | Phase 1 | Status: COMPLETED